Kurtz Ronald M MD's Form 4 filing
RxSight, Inc. (RXST) · filed May 6, 2024
- Accession no.
- 0000950170-24-053667
- Filed
- May 6, 2024
- Trade date
- May 3, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.41M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kurtz Ronald M MDCIK 0001295469 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2024 | Common Stock | SSaleDisposed | −40,000 | $60.15 | −$2,406,000 | 764,610 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.